P
PMVP
Pmv Pharmaceuticals, Inc.
1.050
-0.040-3.67%Pre Market: 1.090 +0.040 +3.81%08:19 06/10 EDT
OPEN/PREV CLOSE1.090/1.090
TODAY RANGE1.040-1.118
VOL25
MARKET CAP56.00M
52 WEEK RANGE0.9642-1.880
AVG VOL (3M)389.81K
% TURNOVER0.42%
TURNOVER0
P/E (TTM)-0.7083
% RANGE7.16%
EPS(TTM)-1.4824
P/E(FORWARD)-0.7047
P/B0.6366
BVPS1.649
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP54.12M
SHARES OUTSTANDING53.33M
NEXT EARNINGS08/05-08/10
FREE FLOAT51.55M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·05/19 11:29
PMV Pharmaceuticals (NASDAQ:PMVP) Will Have To Spend Its Cash Wisely
Benzinga·05/13 21:06
12 Health Care Stocks Moving In Wednesday's After-Market Session
Dow Jones·05/13 17:24
PMV Pharmaceuticals Price Target Cut to $5.00/Share From $6.00 by Oppenheimer
Dow Jones·05/13 17:24
PMV Pharmaceuticals Is Maintained at Outperform by Oppenheimer
Reuters·05/13 12:40
PMV PHARMACEUTICALS <PMVP.O>: OPPENHEIMER CUTS TARGET PRICE TO $5 FROM $6
Reuters·05/13 07:31
U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic
TipRanks·05/12 16:19
PMV Pharmaceuticals reports Q1 EPS (34c), consensus (38c)
Seeking Alpha·05/12 12:25
PMV Pharmaceuticals GAAP EPS of -$0.34
Reuters·05/12 12:11
PMV Pharmaceuticals' Q1 net loss widens
Benzinga·05/12 12:03
PMV Pharma Q1 EPS $(0.34) Beats $(0.39) Estimate
PUBT·05/12 12:02
PMV Pharma Q1 FY26 net loss widens to $18.04 million
Same Industry
Name/Symbol
Change%
Price